Effect of allisartan on blood pressure and left ventricular hypertrophy through Kv1.5 channels in hypertensive rats

Background The objective of the present work was to study the anti-hypertensive effect of allisartan on blood pressure (BP) and in facilitating left ventricular remodeling through voltage-gated potassium channels (Kv) 1.5 channels. Methods A total of 30 SD rats were randomly divided into sham operat...

Full description

Bibliographic Details
Main Authors: Chunfang Xu, Ziying Zhao, Wang Yuan, Zhao Fengping, Yan Zhiqiang, Zhang Xiaoqin
Format: Article
Language:English
Published: Taylor & Francis Group 2022-04-01
Series:Clinical and Experimental Hypertension
Subjects:
Online Access:http://dx.doi.org/10.1080/10641963.2021.2018597
_version_ 1797681114323615744
author Chunfang Xu
Ziying Zhao
Wang Yuan
Zhao Fengping
Yan Zhiqiang
Zhang Xiaoqin
author_facet Chunfang Xu
Ziying Zhao
Wang Yuan
Zhao Fengping
Yan Zhiqiang
Zhang Xiaoqin
author_sort Chunfang Xu
collection DOAJ
description Background The objective of the present work was to study the anti-hypertensive effect of allisartan on blood pressure (BP) and in facilitating left ventricular remodeling through voltage-gated potassium channels (Kv) 1.5 channels. Methods A total of 30 SD rats were randomly divided into sham operation group, hypertension control group, and allisartan treatment group. Hypertension was induced by renal artery stenosis. The animals of treatment group were administered with allisartan once a day at a dose of 30 mg/kg body weight through an oral gavage for 4 weeks. The heart function of animals post 4 weeks of treatment was evaluated by echocardiography, and the degree of ventricular hypertrophy and cardiomyocyte hypertrophy were evaluated by histomorphology. The expression of Kv1.5 is detected by real-time quantitative polymerase chain reaction while Western blotting was used to detect the protein expression. Results Four weeks after renal artery stenosis, a significant difference was observed in the whole heart ratio, left heart ratio, and cardiomyocyte area between allisartan treatment group and the hypertension control group (P< .01). A significant decrease in BP of allisartan treatment group compared to hypertension control group (P< .01) was observed. The expression of Kv1.5 mRNA was increased significantly (P< .01) in allisartan treatment group compared to hypertension control group. Western blot analysis also confirmed the increased expression of Kv1.5 channel. Conclusion The results showed that allisartan lowers BP and improves left ventricular remodeling through increased expression of Kv1.5 mRNA.
first_indexed 2024-03-11T23:40:11Z
format Article
id doaj.art-a73cd77457ba438fa9eb865080d62246
institution Directory Open Access Journal
issn 1064-1963
1525-6006
language English
last_indexed 2024-03-11T23:40:11Z
publishDate 2022-04-01
publisher Taylor & Francis Group
record_format Article
series Clinical and Experimental Hypertension
spelling doaj.art-a73cd77457ba438fa9eb865080d622462023-09-19T16:04:07ZengTaylor & Francis GroupClinical and Experimental Hypertension1064-19631525-60062022-04-0144319920710.1080/10641963.2021.20185972018597Effect of allisartan on blood pressure and left ventricular hypertrophy through Kv1.5 channels in hypertensive ratsChunfang Xu0Ziying Zhao1Wang Yuan2Zhao Fengping3Yan Zhiqiang4Zhang Xiaoqin5Southern Medical University Affiliated FengXian HospitalEast Hospital, Tongji University School of MedicineSouthern Medical University Affiliated FengXian HospitalSouthern Medical University Affiliated FengXian HospitalSouthern Medical University Affiliated FengXian HospitalSouthern Medical University Affiliated FengXian HospitalBackground The objective of the present work was to study the anti-hypertensive effect of allisartan on blood pressure (BP) and in facilitating left ventricular remodeling through voltage-gated potassium channels (Kv) 1.5 channels. Methods A total of 30 SD rats were randomly divided into sham operation group, hypertension control group, and allisartan treatment group. Hypertension was induced by renal artery stenosis. The animals of treatment group were administered with allisartan once a day at a dose of 30 mg/kg body weight through an oral gavage for 4 weeks. The heart function of animals post 4 weeks of treatment was evaluated by echocardiography, and the degree of ventricular hypertrophy and cardiomyocyte hypertrophy were evaluated by histomorphology. The expression of Kv1.5 is detected by real-time quantitative polymerase chain reaction while Western blotting was used to detect the protein expression. Results Four weeks after renal artery stenosis, a significant difference was observed in the whole heart ratio, left heart ratio, and cardiomyocyte area between allisartan treatment group and the hypertension control group (P< .01). A significant decrease in BP of allisartan treatment group compared to hypertension control group (P< .01) was observed. The expression of Kv1.5 mRNA was increased significantly (P< .01) in allisartan treatment group compared to hypertension control group. Western blot analysis also confirmed the increased expression of Kv1.5 channel. Conclusion The results showed that allisartan lowers BP and improves left ventricular remodeling through increased expression of Kv1.5 mRNA.http://dx.doi.org/10.1080/10641963.2021.2018597renal artery stenosis hypertensionpotassium channelleft ventricular hypertrophyhypertensionallisartan
spellingShingle Chunfang Xu
Ziying Zhao
Wang Yuan
Zhao Fengping
Yan Zhiqiang
Zhang Xiaoqin
Effect of allisartan on blood pressure and left ventricular hypertrophy through Kv1.5 channels in hypertensive rats
Clinical and Experimental Hypertension
renal artery stenosis hypertension
potassium channel
left ventricular hypertrophy
hypertension
allisartan
title Effect of allisartan on blood pressure and left ventricular hypertrophy through Kv1.5 channels in hypertensive rats
title_full Effect of allisartan on blood pressure and left ventricular hypertrophy through Kv1.5 channels in hypertensive rats
title_fullStr Effect of allisartan on blood pressure and left ventricular hypertrophy through Kv1.5 channels in hypertensive rats
title_full_unstemmed Effect of allisartan on blood pressure and left ventricular hypertrophy through Kv1.5 channels in hypertensive rats
title_short Effect of allisartan on blood pressure and left ventricular hypertrophy through Kv1.5 channels in hypertensive rats
title_sort effect of allisartan on blood pressure and left ventricular hypertrophy through kv1 5 channels in hypertensive rats
topic renal artery stenosis hypertension
potassium channel
left ventricular hypertrophy
hypertension
allisartan
url http://dx.doi.org/10.1080/10641963.2021.2018597
work_keys_str_mv AT chunfangxu effectofallisartanonbloodpressureandleftventricularhypertrophythroughkv15channelsinhypertensiverats
AT ziyingzhao effectofallisartanonbloodpressureandleftventricularhypertrophythroughkv15channelsinhypertensiverats
AT wangyuan effectofallisartanonbloodpressureandleftventricularhypertrophythroughkv15channelsinhypertensiverats
AT zhaofengping effectofallisartanonbloodpressureandleftventricularhypertrophythroughkv15channelsinhypertensiverats
AT yanzhiqiang effectofallisartanonbloodpressureandleftventricularhypertrophythroughkv15channelsinhypertensiverats
AT zhangxiaoqin effectofallisartanonbloodpressureandleftventricularhypertrophythroughkv15channelsinhypertensiverats